Read + Share
Takeda S, Namisaki T, Tsuji Y, Fujimoto Y, et al. Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable
Hepatocellular Carcinoma: A Real-world Retrospective Study. Anticancer Res 2022;42:5465-5473.
PMID: 36288892
|
 |
|
Takeda S, Namisaki T, Tsuji Y, Fujimoto Y, et al. Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable
Hepatocellular Carcinoma: A Real-world Retrospective Study. Anticancer Res 2022;42:5465-5473.
PMID: 36288892
|
|
|
|